Engineering services company L&T Technology Services Limited (NSE: LTTS) announced on Monday that it has partnered with AI computing company NVIDIA to unveil Gen AI and advanced software-defined architecture for medical devices, focusing on endoscopy. The collaborative effort aims to address industry challenges related to custom hardware components, enhancing image quality and scalability for medical applications.
The scalable platform integrates a comprehensive image processing pipeline, incorporating noise reduction, edge and contrast enhancement, texture and color enhancement and speckle correction. Unique features include AI/ML models for polyp detection during colonoscopies.
Leveraging NVIDIA Holoscan and NVIDIA IGX Orin platforms, the architecture ensures low-latency data transfer, superior image processing and scalability for multiple AI-enabled applications, enhancing visualisation and decision-making support.
L&T Technology Services, a subsidiary of Larsen & Toubro Limited, specializes in Engineering and R&D services, serving Fortune 500 and top ER&D companies globally across various industries. With over 23,800 employees and a vast global presence, the collaboration emphasizes cutting-edge advancements in medical imaging technology.
Johnson & Johnson agrees acquisition of V-Wave
Nightingale Health gains UKCA certification and expands with new laboratory
Talphera enrols first subject in NEPHRO CRRT study
China Pharma Holdings anticipates launch of Dry Eye Disease Therapeutic Device in early 2025
SOPHiA DDM Platform achieves IVDR certification, enhancing diagnostic precision
Medtronic reports FDA approval of Simplera CGM; partners with Abbott
OncoBeta expands Rhenium-SCT (Skin Cancer Therapy) treatment services in Italy
Labcorp's PGDx elio plasma focus Dx receives US FDA De Novo marketing authorisation
Verici Dx announces completion of Thermo Fisher Scientific licensing agreement
Polarean Imaging enters into trade-in agreement with University of Kansas Medical Center